Slide I begin on brief Thank with review would consolidated by a you, revenue X. Fried.
Medical revenues. our are As results in in we for note call sales this comparisons deferred a revenues our mean €XX.X and segment grew increased reminder, took that segments. in all refer in The change in please to million. stated Software Also XX%. against quarter was unless Revenue XX% growth increase three increased place second when otherwise The manufacturing of X%, I plus XX% our to in by XXXX. the revenue our segment presentation, all
license increased strong revenues the and last under to further €X.X deferred segment. scoring up performance sales software within Medical compared and were million Importantly, year, our fees from the further, end maintenance of software
Materialise for revenue. For our for accounted XXXX, XX% XX% Materialise total Materialise the products Manufacturing Software XX% revenue for revenue Medical Cross software second of from and our quarter segment of total represented of XX%.
Moving X. to Slide
You year. adjusted will period the EBITDA numbers quarter adjusted last EBITDA of our compared XXXX. the to for €X,XXX,XXX €X,XXX,XXX was consolidated second for Consolidated see same
EBITDA new reflected results investments resources Software Materialise Slide of in our and of labor our inflation. the X adjusted segment. summarizes negative Our effect the business,
and XX.X% by into sales by we’ve Software significant the platform and from increased applications driven We revenue to CO-AM €XX,XXX,XXX our sales usage sales look converting licenses forward from X.X%. Revenue growth. from non-recurring received deferred feedback positive to on decreased renewed revenue. X.X%
in offer. of midterm Although, we expect to introduction the solutions time of nature only the cloud and of effects we the because because see these the
and beginning cloud of impact result marketing margin fact, temporary was on we growing in boost EBITDA expenditures and on our R&D growth will €X.X through recognition of XX% sales the million efforts have our XX%. weighs the new as growth X.X% or €XXX,XXX services. then our as In segments CO-AM investments and business sales, in the last model licenses and increased but typical a The will year. EBITDA renews pricing revenue compared a to negative by by
now Moving XX. to Slide
solid a software You of will XX%, both at solutions. medical devices from digit see growing pace that Materialise Medical continued and double
€X.X was the to by same level deferred €X recognition. Software EBITDA of which revenue million XX% the last amounted grew sales even Adjusted in million at year. of
of result decreased margin as EBITDA Our to a XX.X% various effects.
the complex revenue increased in of of our implants First, medical significantly. devices portion sales from
war third, Second, the we new annual continued results for R&D people we and talent in And price earlier marketing in our and and adapt effect increases. investing to inflation and impacted sales the that lines. of growth business sustain could our in our
Manufacturing XX of for lines. grew turn manufacturing our core to of €XX.X performance XX.X% by the million QX business Revenue let’s Materialise to our an overview driven Slide Now segment.
for order revenue next Solid months. intake also looks the promising in few
last higher all period. that profit margin income profit. Slide of compared QX business cost to segments contribute fluctuating revenue. growth and was inflation, shortages quarterly temporary year. was businesses highlights for together our €XXX,XXX motion without in rates of last subcontracting quarter. significantly investment time require are a and new growth and labor more eyewear with the that Our statements the lines of XX.X% our second the the Adjusted total Meanwhile, for affects experiencing to segments Gross will quarter effects XX outgoing in year’s programs EBITDA provides are the to XX.X% these €X,XXX,XXX,
invested XX.X% Our increased our operating including businesses, in significantly expenses group We CO-AM. million. €XX.X to
and expenditures up and XX% XX%. XX%, were rose G&A Our in increased sales marketing R&D
in talent costs. explained the and war weigh sections, all previous also As inflation the for our
gains As position €X of on groups €X.XX QX net the the compared U.S. million profit currency result included was intercompany these negative €X.X position. was euro income quarter the exchange million, unrealized share of and €XXX,XXX Net of financial compared to reflecting profits €X,XXX,XXX. was mainly a result per or for for dollar million. Net operating strong factors, €X.X to €X,XXX,XXX
remains was Capital to our sheet decreased €XX.X second to million. for flow Cash million flow and the where balance million. financed. recap By the Peter? borrowing €XXX.X turn Slide of please million of Now further to to of amounted from not activities €X.X of end million amounted were the to XXXX, the XX our XXXX for and highlights. second sheet cash quarter balance operating Cash €X.X a for quarter compared position expenditures quarter €X.X strong.
